Blinded Diagnostics Appoints Jon Klippel As VP, Business Development
Blinded Diagnostics recently announced the expansion of their business development efforts by appointing Jon Klippel as the new Vice President of Business Development. Jon, a 25 year veteran of the medical device and diagnostics industry, will be working from the Saddle Brook office to provide point of care diagnostics solutions to pharmaceutical and biopharmaceutical clients.
"With the addition of Jon Klippel to the team, we plan to expand our reach to many more pharmaceutical companies interested in same day lab test results using point of care diagnostics” said Steve Karuppan, CEO of Blinded Diagnostics. He added that “Jon’s experience is an excellent fit because he has first-hand knowledge of the challenges of providing pharmaceutical companies with practical cost saving services.” Prior to joining Blinded Diagnostics, Jon had responsibility for a range of business development activities at Cegedim Relationship Management, a Life Sciences CRM service provider located in NJ. His medical device background includes both sales and marketing management for wound care products as well as market development for a point-of-care instrument to assist in the early detection of melanoma. Additionally, a large portion of Jon’s career was spent in marketing with Howmedica, the former orthopedic division of Pfizer.
About Blinded Diagnostics
A pioneering contract service organization specializing in sourcing and supporting point of care diagnostic test platforms that provide same day lab test results for pharmaceutical clinical trials. Blinded Diagnostics has a successful track record of expertise in meeting large pharmaceutical company testing needs with thorough knowledge of the protocol design, Investigator training and firmware encryption. As an innovator with partners in point-of-care diagnostics, Blinded Diagnostics is at the forefront of a paradigm shift that brings flexibility and efficiency for trial sponsors. For more information, visit www.blindeddiagnostics.com
SOURCE: Blinded Diagnostics